WE ARE

Developing
first-line,
best-in-class
treatments for
skin diseases and precancerous skin conditions.

Skin diseases impact a patient’s life in more ways than the itch, rash, and dry skin often associated with these conditions. For those affected, the impact of skin disease often comes with mental health issues such as anxiety, social isolation, depression, and a lower quality of life. Currently available treatments for inflammatory skin diseases typically have limited efficacy or strong side effects that severely reduce patient compliance.

acne / rosacea

atopic dermatitis

Pre-cancer / skin cancer

anti-aging / skin aging

Our Purpose

Derm-Biome Pharmaceuticals, Inc. is a Vancouver-based preclinical biopharmaceutical company founded in 2018. We are focused on developing and advancing safe and highly effective topical therapies for inflammatory skin diseases, precancerous skin conditions, and non-melanoma skin cancers, each of which represents a significant unmet need.

Who we’re working with

in the news